18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation

Purpose: Hematologic toxicity (HT) during chemoradiation therapy (CRT) for anal cancer can lead to treatment breaks that compromise efficacy. We hypothesized that CRT-induced HT correlates with changes in active bone marrow (ABM) characterized by pre-/post-CRT positron emission tomography (PET)/comp...

Full description

Bibliographic Details
Main Authors: John M. David, MD, Yong Yue, PhD, Kevin Blas, MD, Andrew Hendifar, MD, Peyman Kabolizadeh, MD, Richard Tuli, MD PhD
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109419300831

Internet

http://www.sciencedirect.com/science/article/pii/S2452109419300831

Similar Items